FluoroPharma Medical, Inc.
CIK 0001402785
Revenue (TTM)
—
FY Mar 2017
Net Income (TTM)
−$1.82M
+35.2% YoY
FY Mar 2017
EPS Diluted (TTM)
−$0.09
−212.5% YoY
FY Mar 2017
Gross Margin
—
FY Mar 2017
Operating Margin
—
FY Mar 2017
Net Margin
—
FY Mar 2017
Free Cash Flow (TTM)
−$2.5M
FY Mar 2017
Cash
$24.72K
FY Mar 2017
Total Debt
—
FY Mar 2017
Shares Outstanding
34.26M sh
FY Mar 2017
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.